CHF patients with and without sarcopenia had similar age, body fat, inflammation markers, HbA1C and lipids, but CHF patients with sarcopenia according to the current European guidelines had higher NT‐proBNP levels and lower BMI, % trunk fat and creatinine clearance, suggesting more advanced heart failure, reduced kidney function and more general wasting. This evidence concerns the gene NPPB and sarcopenia.